This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology®, Gibson et al.1 address an important issue in amyotrophic lateral sclerosis (ALS) genetics; namely, what percentage of isolated or sporadic forms of ALS that have an identifiable genetic factor are likely responsible for disease pathogenesis. To address this, the authors used a 3-step approach: first, they selected 87 patients they diagnosed with sporadic ALS (SALS) and who were of European ancestry (to get as a homogenous a study cohort as possible). They then screened the exons of all 23,000 genes, focusing on variants in the 31 genes earlier linked to ALS, as well as 2 repeat intron sequences in the C9orf72 and ATXN2 genes also known to cause ALS. As with the general population, the patients harbored several genetic variants. The critical question is as follows: which of them are pathogenic?
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the author, if any, are provided at the end of the editorial.
See page 226
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.